9th Tumor Models San Francisco Summit 2025, January 29-30, 2025

Conference

genOway presentation

Event
-
January 22, 2025

genOway's presentation on Wednesday, January 29, 2025 | 4 p.m. PST:

Assessment of translational tumor biology and efficacy in humanized mouse models

  • Outlining BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
  • Investigating human immune cell recruitment into tumor microenvironment in BRGSF-HIS mice
  • Assessment of anti-tumoral compounds in BRGSF-HIS mice
  • Use of hFcγR model to investigate the Fc-mediate effector functions of therapeutic antibodies

9th Tumor Models San Francisco Summit 2025, January 29-30, 2025

Get in touch

Let us know how we can help

Other news & events

NextGen Biomed 2025, London, UK, March 12-14, 2025
Conference
Event
-
Feb 2025
Read on
genOway signs a three-year contract with a global philanthropic organization supporting the development of infectious diseases therapies
Partnership
News
-
Feb 2025
Read on
9th Tumor Models San Francisco Summit 2025, January 29-30, 2025
Conference
genOway presentation
Event
-
Jan 2025
Read on
13th Tumour Models London Summit 2024, December 4-5, 2024
Conference
genOway presentation
Event
-
Dec 2024
Read on
ESMO (European Society For Medical Oncology) 2024, Barcelona, Spain, September 13-17, 2024
Conference
genOway presentation
Event
-
Sep 2024
Read on